Morning Brief — Wednesday, September 9, 2026

Market Overview

U.S. equity futures are under modest pressure as Brent crude surpasses $100/barrel following fresh U.S.-Iran military exchanges near Kharg Island and Jask, reigniting stagflation fears ahead of key inflation data. The macro backdrop is bifurcated: individual stock catalysts (earnings beats, AI conference presentations, biotech trial data) are driving enormous single-stock moves even as the broad tape faces headwinds from rising oil and Treasury yields. Meta’s +6% surge on Muse AI subscription tiers and Apple’s iPhone event provide a tech counterweight, but the energy shock is the dominant macro narrative today.

Claude’s Call

DOWN — Brent at $100+ is a genuine inflation shock that will pressure the Fed’s rate path and compress consumer discretionary multiples; with the S&P 500 already sitting near all-time highs and the energy overhang likely to dominate the tape Wednesday, sellers have the cleaner argument than buyers despite the individual stock bright spots.

Top Movers

ROIV (+18.75%) — $41.48 → $45.60 (+9.9% upside) Thesis: This is the real deal — a Phase 2 “blowout” readout for Mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD) is exactly the kind of binary catalyst that justifies a gap to all-time highs. PH-ILD has limited treatment options, the addressable patient population is substantial, and hedge fund holdings surged 41% in Q2, meaning smart money was already positioned. Technically, ROIV is at a 6-month high of $41.49 with zero overhead resistance — the next meaningful target is the 1.272 fib extension at $45.60. The RSI at 50 is surprisingly uncrowded for an 18% mover, suggesting this isn’t a pure momentum overshoot. Levels: Exit at $45.60 (fib 1.272 extension). Support at $37.93 (fib 23.6%) and $35.73 (fib 38.2%), with the 50-day SMA at $35.56 as the hard floor.

SIG (+17.43%) — $97.08 → $105.72 (+8.9% upside) Thesis: A legitimate earnings-driven move — Signet beat EPS by nearly 30% and raised full-year guidance, which for a specialty retailer in a challenging consumer environment is genuinely impressive. The “more to the report than the numbers” framing from analysts suggests margin improvement or channel mix shift is the hidden driver. At $97.08 the stock is just below the 6-month high of $98.86, making this a near-breakout — a clean close above $99 opens the door to the 1.272 fib extension at $105.72. RSI at 11.33 is the only red flag here — that’s extraordinarily low and likely reflects how badly beaten down this stock was before the print, which actually makes the recovery more durable, not less. Levels: Exit at $105.72 (fib 1.272). Support at $92.91 (fib 23.6%). Stop below $89.23 (fib 38.2%) on any reversal.

SEI (+16.29%) — $63.96 → $93.61 (+46.4% upside) Thesis: Solaris Energy Infrastructure raised Q3, Q4 EBITDA guidance AND initiated Q1 2027 guidance in one shot — that’s a management team with real visibility, not hope. The “from oil fields to data centers” pivot narrative is a legitimate secular driver, and four consecutive up days with a 25%+ week suggests institutional accumulation. Technically SEI is sitting between the 50% and 38.2% fib retracements on the 6-month chart (current price $63.96 vs. fib 38.2% support of $67.81), meaning it’s actually in a recovery channel, not extended. The 1.272 extension at $93.61 is aggressive but achievable if guidance proves conservative. Levels: Exit at $93.61 (fib 1.272 extension). Immediate support at $67.81 (fib 38.2%), deeper support at $63.15 (fib 50%). The SMA-50 at $59.37 is the line in the sand.

SMR (+15.26%) — $11.18 → $15.68 (+40.2% upside) Thesis: Sector sympathy with the AI power/nuclear theme amid Iran tensions — there’s no company-specific news explaining this particular move, and the analyst community is actively divided (Wall Street says buy Oklo, sell NuScale). NuScale reported a 99% plunge in Q2 revenue, which is a brutal fundamental backdrop. This feels like a retail-driven nuclear momentum trade piggybacking on the energy security narrative. RSI at 17.03 and a stock that’s already down 70%+ from highs means the short-squeeze risk is real, but so is the value trap. I’d fade this move rather than chase it. Levels: Resistance at $12.45 (fib 23.6% from 6mo swing). Support at $10.77 (fib 50%). The SMA-50 at $9.15 is where true believers would buy the dip.

AXTI (+12.85%) — $69.56 → $88.90 (+27.8% upside) Thesis: AXT makes indium phosphide (InP) substrates — the picks-and-shovels play on AI data center optical interconnects — and has secured supply agreements with customer deposits through 2031, which is genuinely differentiated revenue visibility in a sector where everyone is guessing. The $100M+ backlog and record InP revenues are real. Technically the stock is deeply under its 6-month high of $140.83, sitting below the 61.8% fib support at $76.64, so today’s move is a bounce from oversold territory, not a breakout. The 50-day SMA at $62.93 is the floor. Levels: Exit at fib 50% retracement of the 6mo swing at $88.90 as a realistic near-term target. Support at $62.93 (SMA-50). Don’t chase above $95 without volume confirmation.

DOCN (+12.64%) — $126.69 → $134.01 (+5.8% upside) Thesis: DigitalOcean’s AI-native cloud strategy pitch at the Goldman Sachs Communacopia conference lit up the tape — 29% revenue growth YoY is the fastest in years, and the AI inference workload pivot gives the SMB cloud story a new narrative. But I’m cautious here: the CFO sold 35,000 shares for $3.8M and the CEO sold 20,483 shares just days ago, and the stock is sitting right at the fib 38.2% retracement support of $134.01 from above. RSI at 2.32 is the most extreme oversold reading on the board, which means a bounce was technically overdue — but a conference catalyst for a stock down 35% in 90 days is not a fundamental re-rating. This is a trading bounce, not a new leg higher. Levels: Exit at $134.01 (fib 38.2% resistance from above, now test). Hard resistance at $152.08 (fib 23.6%). Support at $119.41 (fib 50%) and $124.02 (SMA-50).

CRWV (+11.72%) — $99.83 → $119.77 (+20.0% upside) Thesis: CoreWeave jumped on a Nebius-Palantir deal that validated the neocloud AI infrastructure category — this is sector sympathy, not a company-specific catalyst, and you should price that accordingly. The real story here is CoreWeave’s own 112.5% revenue growth rate, which at an EV/EBITDA of 26.7x (below the peer median of 34.6x) makes this genuinely cheap relative to comps. The stock is sitting right on the 50% fib support at $99.40, which is a technically clean bounce location. If this level holds on a retest, the risk/reward for a swing trade is excellent. Levels: Exit at $119.77 (fib 23.6% resistance). Support at $99.40 (fib 50%) — this is your stop-loss trigger. Below $90.30 (fib 61.8%) the thesis is broken.

LITE (+11.04%) — $978.53 → $1,053.09 (+7.6% upside) Thesis: Lumentum is catching a bid on the broader optical/AI infrastructure theme — Corning’s Verizon megadeal for broadband and AI infrastructure through 2032 is pulling the entire optical supply chain higher. LITE is a direct beneficiary of AI data center optical demand (laser sources, transceivers). At $978.53 the stock is testing near its 6-month high of $1,053.09, with the fib 23.6% support at $946.72 providing a reasonable floor. The RSI at 59.3 is healthy — not overbought. This has legs if the optical infrastructure investment cycle accelerates. Levels: Exit at the 6-month high of $1,053.09. Support at $946.72 (fib 23.6%). SMA-50 at $822.75 is the longer-term floor.

BE (+9.63%) — $277.22 → $292.43 (+5.5% upside) Thesis: Bloom Energy is being added to the S&P 500 in the September quarterly rebalancing — that’s a hard, index-driven demand catalyst that will force passive funds to buy. The “55-day deployment to Oracle data center” story validates the speed-to-power narrative that AI infrastructure customers are screaming for, and the Q2 earnings beat underpins the fundamental case. But at $277.68, the stock is already above the fib 23.6% retracement at $292.43 (which is now resistance) after a 34% week. Be careful — the S&P 500 inclusion is a buy-the-news, sell-the-event setup once rebalancing completes. Levels: Exit at $292.43 (fib 23.6% — first resistance). Support at $259.39 (fib 38.2%). The SMA-50 at $227.04 is the real floor.

INTC (+9.05%) — $104.47 → $117.40 (+12.3% upside) Thesis: Intel is up 300%+ in the past year and today’s 9% move has no fresh company-specific catalyst — this looks like momentum continuation and Reddit retail engagement (trending on WSB). The data center profit story has quadrupled, which is real, but the stock is below its 6-month high of $140.94 and is now testing right at the fib 38.2% support of $102.84, suggesting the bounce is technically constructive. Analysts remain skeptical, and the 50-day SMA at $99.57 is close support. This feels like a coiled spring if the AI infrastructure cycle continues to accelerate — but one bad data point could unwind a year of gains. Levels: Exit at $117.40 (fib 23.6% resistance). Support at $102.84 (fib 38.2%) and SMA-50 at $99.57. Below $91 the bull thesis is seriously impaired.

ASO (+9.82%) — $49.10 → $58.40 (+18.9% upside) Thesis: Clean earnings beat — EPS +10% vs. estimates with raised full-year guidance from a sporting goods retailer in a tough consumer environment. That’s a real, fundamental catalyst. The 11 new store openings and football season tailgate push give the growth story tangible legs. Technically the RSI at 4.44 is profoundly oversold (the stock was clearly being shorted into the print), and the bounce from the 6-month low area near the SMA-50 ($46.80) is the textbook setup. Analyst target of $58.40 offers nearly 19% upside from here. Levels: Exit at $58.40 (analyst consensus target) or $59.61 (6-month high). Support at $46.80 (SMA-50). Stop below $45.

Headlines to Watch

  • Brent crude exceeds $100/barrel on U.S.-Iran strikes near Kharg Island — The single biggest macro risk today; a sustained $100+ oil price resurrects stagflation fears, pressures the Fed, and could trigger a sector rotation out of growth/tech into energy — watch XLE and energy-adjacent names like SEI and ERO.

  • Meta rises 6% on Muse AI agent with paid subscription tiers — This is the first major consumer AI subscription monetization proof point from a mega-cap; if Meta can demonstrate ARPU expansion from AI, it validates the entire AI monetization thesis and likely lifts NVDA, CRWV, and other AI infrastructure plays.

  • Bloom Energy set to join S&P 500 in September rebalancing — Passive fund inflows are a guaranteed, non-discretionary demand catalyst; watch for continued institutional accumulation into BE heading into rebalancing day.

  • Apple iPhone event today — In the current macro environment (oil spike, yield pressure), Apple needs to deliver a genuine AI/hardware surprise to move the tape; a disappointing event could be the catalyst that tips tech into a broader risk-off session.

  • Amgen falls 10%, Novartis drops 14% on Lp(a) drug class concerns — A Novartis trial failure is clouding an entire cardiovascular drug class; biotech investors should map their exposure carefully — but Roivant’s separate PH-ILD success shows the market is still rewarding clean binary readouts.

  • Signet Jewelers raises full-year earnings outlook post Q2 beat — A discretionary retailer raising guidance when oil is spiking and consumer confidence is shaky is a meaningful signal; either the wedding/engagement cycle is more resilient than feared, or Signet-specific execution is carrying the day.

  • ServiceTitan -22% despite earnings beat — The clearest example today of “sell the guidance” — record free cash flow and an AI pitch weren’t enough when valuation was stretched; use this as a warning for any high-multiple SaaS name you’re holding into earnings.

Claude’s Top Picks

SIG (+17.43% today, +19.47% week) — $97.08 → $105.72 (+8.9% upside) Valuation: No forward P/E comp provided, but a specialty jeweler at ~$97 with raised FY guidance after a 30% beat is trading well below luxury/discretionary peers on a price-to-forward-earnings basis. Upside: EPS beat of nearly 30% with a raised FY outlook is a multi-session catalyst; the stock is just under the 6-month high of $98.86 and a clean break above $99 opens the path to $105.72 (fib 1.272 extension) with no meaningful resistance in between. Risk: Oil at $100+ hitting consumer confidence could disproportionately hit discretionary/jewelry spending and cause management to walk back guidance within 60 days.

CRWV (+11.72% today, +17.6% week) — $99.83 → $119.77 (+20.0% upside) Valuation: CHEAP vs. peers — EV/EBITDA of 26.7x vs. peer median 34.6x with 112.5% revenue growth; this is one of the cheapest high-growth AI infrastructure names on the board on a growth-adjusted basis. Upside: The stock is bouncing off the 50% fib support at $99.40, which is a technically ideal entry; 112.5% revenue growth at a discount to peers is a powerful combination that institutional investors will close over the next several weeks. Risk: Sector sympathy drove today’s specific move (Nebius-Palantir deal, not CRWV-specific news), which makes the near-term catalyst fragile — if AI sentiment sours, this loses the support level fast.

ASO (+9.82% today, +14.69% week) — $49.10 → $58.40 (+18.9% upside) Valuation: No forward P/E comp in the dataset, but at ~$49 with EPS of $5.66 this quarter the trailing P/E is under 10x — deeply cheap for a retailer growing earnings and raising guidance. Upside: RSI at 4.44 pre-earnings was absurdly oversold, and the combination of an EPS beat, revenue in-line, raised guidance, 11 new stores, and a football tailgate catalyst gives bulls multiple levers; the analyst target of $58.40 is 19% away. Risk: The broader consumer discretionary sector faces real headwinds if Brent at $100+ persists — gas prices eat directly into the sporting goods customer’s discretionary budget.

AXTI (+12.85% today, +14.77% week) — $69.56 → $88.90 (+27.8% upside) Valuation: No forward P/E comp provided, but AXT trades at a significant discount to the broader semiconductor equipment space despite having contracted revenue (customer deposits through 2031) that most peers lack. Upside: InP substrate demand for AI optical interconnects is a genuine multi-year secular driver with a $100M+ backlog; the stock is still 50% below its 6-month high of $140.83, meaning today’s bounce is recovery, not extension. Risk: The SMA-50 at $62.93 is the key level — if that breaks, the stock could retest the 6-month low of $36.97, which would be catastrophic; also, the vol ratio of 0.13 is thin, meaning any sell program hits the stock hard.

SEI (+16.29% today, +25.98% week) — $63.96 → $93.61 (+46.4% upside) Valuation: No forward P/E comp, but an energy infrastructure company that raised EBITDA guidance for three consecutive quarters and initiated forward guidance deserves a premium to utility/midstream peers. Upside: The “oil field to data center” pivot is the most investable energy narrative of 2026 — management’s willingness to initiate Q1 2027 guidance signals genuine business visibility, not hope, and four consecutive up days suggest institutional accumulation is ongoing. Risk: At $63.96 with a 25% week, a pullback to the fib 38.2% support ($67.81) is the best entry on weakness — chasing the open today means you’re buying into the fourth day of a run with no fresh catalyst, and the vol ratio of 0.08 suggests thin liquidity.

Avoid

NNE (+9.2% today, +5.8% week) — RSI at 1.22 is technically the most oversold name on the board, yet the bounce has no company-specific catalyst — pure energy security/nuclear sector sympathy. Nano Nuclear is a pre-revenue microreactor development company with its first deployment targeted for 2028 at the earliest; a 9% move on Iran geopolitics is a retail-driven sympathy trade that historically fades within 48-72 hours.

SMR (+15.26% today) — NuScale reported a 99% revenue decline in Q2 and is down 70%+ from its highs; analysts are actively recommending selling this name vs. buying Oklo. A 15% move with no new company news, a $4 billion valuation that analysts call “hard to justify,” and a fib 23.6% resistance at $12.45 just above current price makes this a sell-the-rip situation.

EOSE (+10.82% today, +33.54% week) — Up 33% on the week and at $4.30, Eos Energy is a high-execution-risk long-duration battery company with a stock that analysts have cut fair value estimates on (from $7.89 to $6.67). The Google/MN8 deal is validating but the stock has already priced it in with a 33% weekly run; at $4.30 against a revised analyst fair value of $6.67, risk/reward is no longer compelling, and dilution risk from capital needs is real and ongoing.

WSB Sentiment Check

MU — WSB says: BULLISH (80% bullish, 148 mentions, 369 upvotes) Claude says: AGREE — MU at $996 is sitting right at the fib 23.6% support level of $1,002.95 after pulling back from its 6-month high of $1,213.37; with AI memory demand (HBM) still accelerating and the stock 18% off highs, this is a technically constructive setup for a bounce. WSB is right for the right reasons here.

NVDA — WSB says: BULLISH (80% bullish, 129 mentions, 695 upvotes) Claude says: PARTIALLY AGREE — NVDA at $225.15 is between the fib 23.6% support ($218.83) and its 6-month high ($235.47), with the SMA-50 at $211.83 as the key floor. The bull case is intact but Jensen Huang’s “AGI is here” declaration and the market’s muted response is a yellow flag — the stock needs a new earnings catalyst to break above $235, and oil at $100 creates a macro headwind for multiple expansion. Good stock, not a great entry today.

AGI — WSB says: BEARISH (30% bullish, 93 mentions, 320 upvotes) Claude says: AGREE — AGI (Alamos Gold) at $37.70 is sitting below the fib 50% retracement of $39.44 from its 6-month high of $51.06, and the WSB bearish sentiment reflects a stock that’s given up significant ground. However, with dollar weakness as a macro theme and gold prices rising (per the IBD 50 commentary), this bear call could be wrong — WSB may be confusing “AI AGI” with the gold mining ticker. If you’re in gold miners, the macro setup is actually supportive.

META — WSB says: BULLISH (80% bullish, 93 mentions, 246 upvotes) Claude says: AGREE — Meta at $645.12 is right at the fib 23.6% support of $649.52 after a strong week, with the Muse AI subscription launch giving the stock a genuine new monetization narrative. The SMA-50 at $598.41 is well below, meaning there’s a cushion. At 80% bullish with real fundamental news (AI subscription tiers, +6% day), this is one of the cleanest setups on the WSB list.

NBIS — WSB says: BULLISH (80% bullish, 65 mentions, 150 upvotes) Claude says: PARTIALLY AGREE — Nebius at $249.65 pulled back from its 20-day high of $277.68 and sits between the fib 23.6% support of $240.80 and recent resistance. The Palantir deal selection of Nebius as an AI-native cloud partner is a genuine validator for the neocloud thesis, and with 80% of CRWV’s revenue growth profile at a similar stage, there’s real institutional interest. But the stock is down from $286.69 six-month high with no clear technical breakout — it’s a hold, not an aggressive add at today’s levels.

Earnings Scorecard

TTAN (ServiceTitan) — REPORTED | Stock: -22.3% | Reported: Yesterday Beat on EPS vs. estimates, delivered record free cash flow and AI traction — yet the stock is down 22%. Classic high-multiple SaaS “sell the guidance” — the numbers weren’t bad, but next-quarter guidance likely disappointed relative to the sky-high bar embedded in the valuation. Analyst target of $111 is 50%+ above current price, suggesting this is now a buy-the-dip for patient investors, but wait for the dust to settle — momentum sellers aren’t done yet.

CASY (Casey’s General Stores) — REPORTED | Stock: -17.2% | Reported: Yesterday Earnings beat but same-store sales growth missed Street views — for a convenience/fuel retailer, comps are the primary valuation driver, so the miss hit where it hurts most. With Brent at $100+ today, the fuel margin outlook adds another layer of complexity. The $936 analyst target vs. current price suggests significant over-reaction, but don’t catch this falling knife until same-store sales trends clarify. Hold off.

ASO (Academy Sports) — REPORTED | Stock: +9.8% | Reported: Today Before Open EPS beat by +10%, raised full-year guidance — the reaction looks justified given how oversold the stock was (RSI 4.44 pre-print). Analyst target of $58.40 implies another 19% from current levels, suggesting the market hasn’t fully re-rated the name yet. Buy-the-dip on any pullback toward $46-47 (SMA-50).

ABM (ABM Industries) — REPORTED | Stock: +7.6% | Reported: Yesterday Record revenue and raised guidance for Q3 — ABM is a B2B facility services company and this is a clean, fundamental beat with no obvious overhang. At $54 analyst target with the stock likely in the high $40s, there’s still upside. Reaction appears justified and sustainable — not a momentum trade but a solid value compounder.

ADYEY (Adyen) — REPORTED | Stock: -4.8% | Reported: Yesterday Revenue growth and raised guidance should have been a positive catalyst, yet the stock fell nearly 5%. Adyen trades at a premium valuation and the market may be penalizing the pace of growth vs. prior hyper-growth years. The 11% jump on acquisition news earlier suggests the market is bifurcated on organic vs. inorganic growth quality. Cautious hold — the valuation premium requires execution beyond “raised guidance.”

AVO (Mission Produce) — REPORTED | Stock: +2.8% | Reported: Yesterday Record volumes and synergy upside on a $0.03 EPS print — modest beat, modest reaction, appropriate. Nothing to see here from a trading perspective. Analyst target of $16.50 offers meaningful upside if avocado pricing normalizes.

ADBE (Adobe) — REPORTED | Stock: +0.1% | Reported: Yesterday After Close Adobe printed $17.47 EPS and the stock went nowhere — the market was braced for a potential AI disruption narrative and instead got a steady beat. With analyst target around $277 and the stock’s actual price presumably well above that (given the analyst target is below current), Adobe is fully priced and the AI fear premium remains. Hold, don’t add.

KR (Kroger) — REPORTED | Stock: -0.3% | Reported: Yesterday $1.71 EPS with effectively zero stock reaction — Kroger is in a “show me” phase post the Albertsons deal fallout. Flat reaction to a beat is a mild negative signal. Not actionable today.

M (Macy’s) — REPORTED | Stock: +0.3% | Reported: Yesterday $2.42 EPS with near-zero reaction — Macy’s is a structural decline story with quarterly bounces. The micro-reaction tells you the market isn’t re-rating the business. Pass.

This brief is for informational purposes only and does not constitute investment advice. All technical levels are derived from the 6-month swing data provided. Past performance does not guarantee future results.